(Last Updated On: January 14, 2024)

CDA Section 230 Groundbreaking Decision in California Civil Case

Has the Dam Finally Broken or is it just a Leak?

Author:
•  SCARS Editorial Team – Society of Citizens Against Relationship Scams Inc.

Article Abstract

NOTE: This article about the Communications Decency Act CDA Section 230 is not intended to be a legal opinion. SCARS is not a law firm nor are licensed attorneys. This is an analysis of this case based on the need to understand the implications for potential future cases and rulings. SCARS has long suggested that social media applications could be considered defective and dangerous products, and we are gratified to see this concept finally emerge in this case.

In the Case of Neville v. Snap – Applying the Communications Decency Act CDA Section 230 in Groundbreaking Decision in California Civil Case

Judge Rejects Snap’s Section 230 Defense in Neville v. Snap

Has the Section 230 immunity Dam Finally Broken or is it just a Leak?

At this Stage of the Case

The complainants, who are parents of individuals using Snapchat and experienced overdoses after buying fentanyl from other Snapchat users, filed a lawsuit against Snapchat, alleging various tort claims. Seeking to overcome the evident Section 230 protection, the plaintiffs employed the common Lemmon v. Snap strategy, asserting their lawsuit centered on Snapchat’s inherent product design decisions rather than the content provided by drug dealers.

Plaintiffs disavow any claim based upon Snap’s activities as a publisher of the third-party (drug seller) content. That is, plaintiffs do not contend that Snap is liable for failing to eliminate or otherwise moderate some or all of the third-party drug sellers’ content. Instead, plaintiffs’ sole focus, they say, is on (1) Snap’s alleged independent tortious conduct and (2) Snapchat (a “feature-packed social media app.”) as a defective product.

The court rejected Snap’s assertion that it was immune because of the CDA Section 230 and rejected Snapchat’s motion to dismiss.

So the question is, does this open the door for similar complaints against other social media platforms to bypass CDA Section 230 immunities?

SCARS Analysis

In the case of Neville v. Snap, parents of Snapchat users who suffered overdoses from fentanyl purchased on the platform sued Snapchat for various tort claims. To overcome Section 230 immunity, they framed the lawsuit around Snap’s first-party product design choices, not the content of the drug dealers.

The judge, deviating unexpectedly, rejected most of Snapchat’s motion to dismiss, arguing that Snap’s alleged independent tortious conduct and Snapchat as a defective product were distinct from the drug sellers’ content. This decision challenges Section 230 jurisprudence, potentially diminishing the immunity’s effectiveness if such doctrinal rephrasing becomes a precedent.

The legal implications for other social media platforms from the Neville v. Snap case are potentially significant, as it challenges the traditional application of Section 230 immunity. Section 230 of the Communications Decency Act provides broad protections to online platforms, shielding them from liability for content posted by users. However, the judge in this case rejected Snap’s Section 230 defense, arguing that the plaintiffs focused on Snap’s alleged independent tortious conduct and the defective nature of Snapchat as a product, rather than the content of the drug dealers.

  1. Increased Scrutiny on Product Design Choices: Platforms may face more scrutiny over their product design choices and features. If plaintiffs can successfully argue that a platform’s design contributes to harm independently of user-generated content, it could open the door to liability.
  2. Potential Erosion of Section 230 Protections: If the decision in Neville v. Snap sets a precedent, it might encourage plaintiffs to reframe their claims to target platform design and features rather than user-generated content. This could erode the broad immunity that Section 230 has traditionally provided.
  3. Need for Clarity on Tangibility Distinction: The court’s rejection of the tangible/intangible distinction may lead to confusion regarding the application of product liability claims to online services. Clarity is needed on whether strict product liability laws can be applied to intangible services like social media platforms.
  4. Impact on Nomenclature Battles: The case highlights the importance of the terms used to describe platforms (e.g., service, app, product). The nomenclature battles could become more critical in determining the applicable legal standards and analogies.
  5. Potential Appeal and Precedent Setting: The case is likely to be appealed, and the outcome at the appellate level will be crucial. If the decision stands, it may set a precedent that challenges the broad protections traditionally afforded to online platforms under Section 230.

Summary

In summary, the Neville v. Snap case introduces legal uncertainties and potential challenges to the established understanding of Section 230 immunity. Social media platforms should closely monitor developments in this case and consider the implications for their own liability protections.

SCARS Resources:

PLEASE NOTE: Psychology Clarification

The following specific modalities within the practice of psychology are restricted to psychologists appropriately trained in the use of such modalities:

  • Diagnosis: The diagnosis of mental, emotional, or brain disorders and related behaviors.
  • Psychoanalysis: Psychoanalysis is a type of therapy that focuses on helping individuals to understand and resolve unconscious conflicts.
  • Hypnosis: Hypnosis is a state of trance in which individuals are more susceptible to suggestion. It can be used to treat a variety of conditions, including anxiety, depression, and pain.
  • Biofeedback: Biofeedback is a type of therapy that teaches individuals to control their bodily functions, such as heart rate and blood pressure. It can be used to treat a variety of conditions, including stress, anxiety, and pain.
  • Behavioral analysis: Behavioral analysis is a type of therapy that focuses on changing individuals’ behaviors. It is often used to treat conditions such as autism and ADHD.
    Neuropsychology: Neuropsychology is a type of psychology that focuses on the relationship between the brain and behavior. It is often used to assess and treat cognitive impairments caused by brain injuries or diseases.

SCARS and the members of the SCARS Team do not engage in any of the above modalities in relationship to scam victims. SCARS is not a mental healthcare provider and recognizes the importance of professionalism and separation between its work and that of the licensed practice of psychology.

SCARS is an educational provider of generalized self-help information that individuals can use for their own benefit to achieve their own goals related to emotional trauma. SCARS recommends that all scam victims see professional counselors or therapists to help them determine the suitability of any specific information or practices that may help them.

SCARS cannot diagnose or treat any individuals, nor can it state the effectiveness of any educational information that it may provide, regardless of its experience in interacting with traumatized scam victims over time. All information that SCARS provides is purely for general educational purposes to help scam victims become aware of and better understand the topics and to be able to dialog with their counselors or therapists.

It is important that all readers understand these distinctions and that they apply the information that SCARS may publish at their own risk, and should do so only after consulting a licensed psychologist or mental healthcare provider.

Opinions

The opinions of the author are not necessarily those of the Society of Citizens Against Rleationship Scams Inc. The author is solely responsible for the content of their work. SCARS is protected under the Communications Decency Act (CDA) section 230 from liability.

Disclaimer:

SCARS IS A DIGITAL PUBLISHER AND DOES NOT OFFER HEALTH OR MEDICAL ADVICE, LEGAL ADVICE, FINANCIAL ADVICE, OR SERVICES THAT SCARS IS NOT LICENSED OR REGISTERED TO PERFORM.

IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE FOLLOWING ANY MEDICALLY RELATED INFORMATION PRESENTED ON OUR PAGES.

ALWAYS CONSULT A LICENSED ATTORNEY FOR ANY ADVICE REGARDING LEGAL MATTERS.

A LICENSED FINANCIAL OR TAX PROFESSIONAL SHOULD BE CONSULTED BEFORE ACTING ON ANY INFORMATION RELATING TO YOUR PERSONAL FINANCES OR TAX RELATED ISSUES AND INFORMATION.

SCARS IS NOT A PRIVATE INVESTIGATOR – WE DO NOT PROVIDE INVESTIGATIVE SERVICES FOR INDIVIDUALS OR BUSINESSES. ANY INVESTIGATIONS THAT SCARS MAY PERFORM IS NOT A SERVICE PROVIDED TO THIRD-PARTIES. INFORMATION REPORTED TO SCARS MAY BE FORWARDED TO LAW ENFORCEMENT AS SCARS SEE FIT AND APPROPRIATE.

This content and other material contained on the website, apps, newsletter, and products (“Content”), is general in nature and for informational purposes only and does not constitute medical, legal, or financial advice; the Content is not intended to be a substitute for licensed or regulated professional advice. Always consult your doctor or other qualified healthcare provider, lawyer, financial, or tax professional with any questions you may have regarding the educational information contained herein. SCARS makes no guarantees about the efficacy of information described on or in SCARS’ Content. The information contained is subject to change and is not intended to cover all possible situations or effects. SCARS does not recommend or endorse any specific professional or care provider, product, service, or other information that may be mentioned in SCARS’ websites, apps, and Content unless explicitly identified as such.

The disclaimers herein are provided on this page for ease of reference. These disclaimers supplement and are a part of SCARS’ website’s Terms of Use

Legal Notices: 

All original content is Copyright © 1991 – 2023 Society of Citizens Against Relationship Scams Inc. (Registered D.B.A SCARS) All Rights Reserved Worldwide & Webwide. Third-party copyrights acknowledge.

U.S. State of Florida Registration Nonprofit (Not for Profit) #N20000011978 [SCARS DBA Registered #G20000137918] – Learn more at www.AgainstScams.org

SCARS, SCARS|INTERNATIONAL, SCARS, SCARS|SUPPORT, SCARS, RSN, Romance Scams Now, SCARS|INTERNATION, SCARS|WORLDWIDE, SCARS|GLOBAL, SCARS, Society of Citizens Against Relationship Scams, Society of Citizens Against Romance Scams, SCARS|ANYSCAM, Project Anyscam, Anyscam, SCARS|GOFCH, GOFCH, SCARS|CHINA, SCARS|CDN, SCARS|UK, SCARS|LATINOAMERICA, SCARS|MEMBER, SCARS|VOLUNTEER, SCARS Cybercriminal Data Network, Cobalt Alert, Scam Victims Support Group, SCARS ANGELS, SCARS RANGERS, SCARS MARSHALLS, SCARS PARTNERS, are all trademarks of Society of Citizens Against Relationship Scams Inc., All Rights Reserved Worldwide

Contact the legal department for the Society of Citizens Against Relationship Scams Incorporated by email at legal@AgainstScams.org